Cyproheptadine Hydrochloride Tablet
Product Images NDC 70518-3517

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70518-3517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a prescription medication which contains Cypreheptadine HCI, 4mg in each tablet. It comes in a pack of 30 tablets and is manufactured by Quagen Pharmaceuticals LLC based in West Caldwell, NJ. It must be stored at room temperature between 20 and 25 °C (88-77°F). The medication has been repackaged by RemedyRepack Inc., Indiana, PA. The package insert should be consulted for direction of use.*
FDA Label Image

Image Description (Chemsture)

Image Description (Chemsture)
This text provides information about the molecular weight of the compound CoHN-HC1, which is 350.89.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.